AIM ImmunoTech Inc. (AMEX: AIM) last traded at $0.258, up 2.09% on the session. The quote above updates while this page is open; the figures below are drawn from AIM ImmunoTech Inc.’s own filings and are restated only when a new one is published.
AIM ImmunoTech Inc. trades on AMEX under the ticker AIM. Its market capitalisation is $7.87 million.
Valuation measures for AIM ImmunoTech Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $7.87M |
|---|---|
| Enterprise value | $2.95M |
| Price / sales | 82.80 |
| Price / book | 1.02 |
| Beta | 0.47 |
Trailing-twelve-month figures tagged in AIM ImmunoTech Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $95.0K |
|---|---|
| Net income (TTM) | -$14.27M |
| Operating margin | -11724.21% |
| Return on equity | -184.27% |
| Cash | $9.90M |
Range and volume for AIM over the past 52 weeks.
| 52-week high | $2.89 |
|---|---|
| 52-week low | $0.190 |
| Volume | 864.0K |
| Average volume | 19.61M |
| Previous close | $0.253 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.